FDA weighs multiple views regarding the Biologics Price Competition and Innovation Act.
Elizabeth S. Retersdorf
Advertisement
Articles by Elizabeth S. Retersdorf
Advertisement
Latest Updated Articles
- Advocating for Biosimilar Approval Standards Under BPCI
Published: September 1st 2011 | Updated:
Advertisement
Advertisement
